Fertility Outcomes in 104 Consecutive Pediatric and Young Adult High-Grade Osteosarcoma Survivors Followed Over a 45-Year Period.

J Am Acad Orthop Surg · Jul 01 2026 · Recent

Lamo-Espinosa JM, San-Julián M

From the Department of Orthopaedic Surgery, Biomedical ASCIRES Hospital, Valencia, Spain (San-Julián)

Orthopaedic Oncology Pediatric Orthopaedics

SUMMARY — THE REDUCTIONPediatric and young adult osteosarcoma survivors have high natural fertility rates comparable to the general population, reassuring patients and families during treatment counseling.
Abstract, as published

INTRODUCTION: Chemotherapy regimens in high-grade osteosarcoma have markedly improved survival rates, currently reaching approximately 70%. Concerns persist regarding a long-term effect on fertility. Despite the systematic application of many fertility preservation techniques, few studies specifically address fertility in survivors. Our goal was to assess fertility in patients treated for pediatric and young adult osteosarcoma in a long-term follow-up period.

METHODS: This study was retrospective analysis of osteosarcoma survivors treated at our center from 1980 to 2005. All followed a standardized chemotherapy protocol. In cases where contact could not be established at the time of the follow-up for their osteosarcoma, telephone interviews were conducted, querying about pregnancy desires and difficulties. In case of difficulties, we further investigated about the possible reasons behind them.

RESULTS: Of 116 consecutive patients initially enrolled, 104 were contacted; 67 (36 women, 31 men) desired pregnancy. Mean age at the beginning of treatment was 16.9 (4 to 33) years. The mean age at the end of follow-up was 46.8 (31 to 64) years, with an average follow-up period of 359 (156 to 480) months. Among the 36 women desiring pregnancy, only 1 (2.7%) faced fertility challenges due to chemotherapy. Of the 31 men desiring pregnancy, 4 (12.9%) experienced difficulties due to azoospermia secondary to chemotherapy and in two cases, the cause is unknown because no fertility studies were conducted for the couple. No discernible chemotherapy dosage differences were found between patients with fertility issues and those without.

CONCLUSIONS: Survivors of pediatric and young adult osteosarcoma exhibit a high success rate in achieving normal conception and childbirth, aligning with the general population. To inform pediatric and adolescent patients with osteosarcoma, as well as their parents, about the high success rate associated with achieving a normal conception and childbirth should be the standard.

Featured in the 2026-06-21 issue.

← Primary osseous chest wall sarcomas: Oncological and surgical…Incidence patterns and trends of chordoma in the United State… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.